247 related articles for article (PubMed ID: 31672622)
1. A two-step precise targeting nanoplatform for tumor therapy via the alkyl radicals activated by the microenvironment of organelles.
Wang L; Niu X; Song Q; Jia J; Hao Y; Zheng C; Ding K; Xiao H; Liu X; Zhang Z; Zhang Y
J Control Release; 2020 Feb; 318():197-209. PubMed ID: 31672622
[TBL] [Abstract][Full Text] [Related]
2. Treatment of triple negative breast cancer by near infrared light triggered mild-temperature photothermal therapy combined with oxygen-independent cytotoxic free radicals.
Li R; Hu X; Shang F; Wu W; Zhang H; Wang Y; Pan J; Shi S; Dong C
Acta Biomater; 2022 Aug; 148():218-229. PubMed ID: 35705171
[TBL] [Abstract][Full Text] [Related]
3. Nanoplatform based on GSH-responsive mesoporous silica nanoparticles for cancer therapy and mitochondrial targeted imaging.
He H; Meng S; Li H; Yang Q; Xu Z; Chen X; Sun Z; Jiang B; Li C
Mikrochim Acta; 2021 Apr; 188(5):154. PubMed ID: 33821295
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeting folic acid-modified nanoplatform based on mesoporous carbon and a bioactive peptide for improved colorectal cancer treatment.
Wang J; Zhang L; Xin H; Guo Y; Zhu B; Su L; Wang S; Zeng J; Chen Q; Deng R; Wang Z; Wang J; Jin X; Gui S; Xu Y; Lu X
Acta Biomater; 2022 Oct; 152():453-472. PubMed ID: 36084923
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-targeted accumulation of oxygen-irrelevant free radicals for enhanced synergistic low-temperature photothermal and thermodynamic therapy.
Hu H; Deng X; Song Q; Yang W; Zhang Y; Liu W; Wang S; Liang Z; Xing X; Zhu J; Zhang J; Shao Z; Wang B; Zhang Y
J Nanobiotechnology; 2021 Nov; 19(1):390. PubMed ID: 34823543
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional nanoparticles for enhanced sonodynamic-chemodynamic immunotherapy with glutathione depletion.
Song J; Tang C; Wang Y; Ba J; Liu K; Gao J; Chang J; Kang J; Yin L
Nanomedicine (Lond); 2024 Jan; 19(2):145-161. PubMed ID: 38270976
[No Abstract] [Full Text] [Related]
9. Triphenylphosphine-docetaxel conjugate-incorporated albumin nanoparticles for cancer treatment.
Battogtokh G; Gotov O; Kang JH; Cho J; Jeong TH; Chimed G; Ko YT
Nanomedicine (Lond); 2018 Feb; 13(3):325-338. PubMed ID: 29338573
[TBL] [Abstract][Full Text] [Related]
10. A Cu-based nanoplatform for near-infrared light amplified multi-mode prostate cancer specific therapy.
Xu B; Niu R; Tang Y; Wang C; Jin L; Wang Y
J Mater Chem B; 2022 Sep; 10(37):7628-7633. PubMed ID: 35894661
[TBL] [Abstract][Full Text] [Related]
11. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
[TBL] [Abstract][Full Text] [Related]
12. A pH-responsive sequential-disassembly nanohybrid for mitochondrial targeting.
Li L; Sun W; Li L; Liu Y; Wu L; Wang F; Zhou Z; Zhang Z; Huang Y
Nanoscale; 2017 Jan; 9(1):314-325. PubMed ID: 27910990
[TBL] [Abstract][Full Text] [Related]
13. A novel near-infrared triggered dual-targeted nanoplatform for mitochondrial combined photothermal-chemotherapy of cancer in vitro.
Wu H; You C; Jiao J; Chen F; Sun B; Zhu X
Nanotechnology; 2019 Jan; 30(3):035601. PubMed ID: 30418947
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel.
Khosravian P; Shafiee Ardestani M; Khoobi M; Ostad SN; Dorkoosh FA; Akbari Javar H; Amanlou M
Onco Targets Ther; 2016; 9():7315-7330. PubMed ID: 27980423
[TBL] [Abstract][Full Text] [Related]
15. PEGylated polyaminoacid-capped mesoporous silica nanoparticles for mitochondria-targeted delivery of celastrol in solid tumors.
Choi JY; Gupta B; Ramasamy T; Jeong JH; Jin SG; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2018 May; 165():56-66. PubMed ID: 29453086
[TBL] [Abstract][Full Text] [Related]
16. Polypyrrole-coated phase-change liquid perfluorocarbon nanoparticles for the visualized photothermal-chemotherapy of breast cancer.
Yang Q; Li P; Ran H; Wan J; Chen H; Chen H; Wang Z; Zhang L
Acta Biomater; 2019 May; 90():337-349. PubMed ID: 30936037
[TBL] [Abstract][Full Text] [Related]
17. Metal-Organic Framework (MOF)-Based Ultrasound-Responsive Dual-Sonosensitizer Nanoplatform for Hypoxic Cancer Therapy.
Zhang C; Xin L; Li J; Cao J; Sun Y; Wang X; Luo J; Zeng Y; Li Q; Zhang Y; Zhang T; Huang P
Adv Healthc Mater; 2022 Jan; 11(2):e2101946. PubMed ID: 34706160
[TBL] [Abstract][Full Text] [Related]
18. Application of water-soluble radical initiator, 2,2'-azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride, to a study of oxidative stress.
Yoshida Y; Itoh N; Saito Y; Hayakawa M; Niki E
Free Radic Res; 2004 Apr; 38(4):375-84. PubMed ID: 15190934
[TBL] [Abstract][Full Text] [Related]
19. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
Song Y; Zhou B; Du X; Wang Y; Zhang J; Ai Y; Xia Z; Zhao G
Biomed Pharmacother; 2020 May; 125():109561. PubMed ID: 32106385
[TBL] [Abstract][Full Text] [Related]
20. A mitochondria-targeted multifunctional nanoplatform combining carbon monoxide delivery with O
Zhang HL; Wang Y; Tang Q; Wang CB; Chen MJ; Yang SP; Liu JG
Colloids Surf B Biointerfaces; 2023 Oct; 230():113513. PubMed ID: 37579528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
